バイオマーカー技術の市場規模、シェア、成長分析、検査タイプ別、製品別、プロファイリング技術別、調査分野別、用途別、地域別 - 産業予測、2025～2032年

バイオマーカー技術の世界市場規模は、2023年に344億米ドルと評価され、2024年の375億6,000万米ドルから2032年には759億6,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは9.2％で成長する見通しです。

世界のバイオマーカー技術市場はヘルスケアに不可欠であり、生物学的マーカーを活用して正常および疾患プロセスや治療反応を評価します。ポリメラーゼ連鎖反応、次世代シーケンシング、イムノアッセイなどの主要技術は、がん、感染症、自己免疫疾患などの診断に不可欠なバイオマーカーの同定に採用されています。さらに、バイオマーカーは開発中の薬物毒性の早期発見を容易にし、個別化医療への取り組みをサポートします。市場の成長が期待される背景には、疾病の蔓延、研究開発努力の強化、早期毒性試験の採用増加などがあります。しかし、高い初期探索コストやバイオマーカー技術の認知度の低さなどの課題が成長を妨げる可能性があります。逆に、新興国には将来の市場拡大の大きな機会があり、革新的なバイオマーカー応用の展望が広がっています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術の進歩

バイオマーカー技術市場規模：検査タイプ別

• 市場概要
• 固形生検
• 液体生検

バイオマーカー技術市場規模：製品別

• 市場概要
• バイオマーカーの特定検証開発調査
  • 消耗品
  • 機器
  • サービス
  • ソフトウェア
• バイオマーカーに基づく日常的な検査
  • 消耗品
  • 機器
  • サービス
  • ソフトウェア

バイオマーカー技術市場規模：プロファイリング技術別

• 市場概要
• 免疫測定
  • ELISA
  • ウエスタンブロット
  • タンパク質マイクロアレイ
• PCR
• イメージング技術
• 質量分析
• 次世代シーズ
• クロマトグラフィー
• 細胞遺伝学
• その他のプロファイリング技術

バイオマーカー技術市場規模：調査分野別

• 市場概要
• ゲノミクス
• プロテオミクス
• メタボロミクス
  • 代謝フラックス
  • リピドミクス
  • その他
• その他の調査分野

バイオマーカー技術市場規模：用途別

• 市場概要
• バイオマーカーの特定検証開発調査
• バイオマーカーに基づく日常的な検査

バイオマーカー技術市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Thermo Fisher Scientific Inc.（United States）
• Bio-Rad Laboratories, Inc.（United States）
• Danaher Corporation（United States）
• Waters Corporation（United States）
• Shimadzu Corporation（Japan）
• Siemens Healthineers AG（Germany）
• Illumina, Inc.（United States）
• PerkinElmer, Inc.（United States）
• Abbott Laboratories（United States）
• Roche Holding AG（Switzerland）
• Merck KGaA（Germany）
• Becton, Dickinson and Company（United States）
• GE Healthcare（United States）
• Bruker Corporation（United States）
• Hologic, Inc.（United States）
• Myriad Genetics, Inc.（United States）
• Bio-Techne Corporation（United States）

結論と推奨事項

Global Biomarker Technologies Market size was valued at USD 34.4 billion in 2023 and is poised to grow from USD 37.56 billion in 2024 to USD 75.96 billion by 2032, growing at a CAGR of 9.2% during the forecast period (2025-2032).

The global biomarker technologies market is vital in healthcare, leveraging biological markers to evaluate normal and disease processes as well as treatment responses. Key technologies such as polymerase chain reaction, next-generation sequencing, and immunoassays are employed to identify biomarkers critical for diagnosing conditions like cancer, infectious diseases, and autoimmune disorders. Furthermore, biomarkers facilitate early detection of drug toxicity in development and support personalized medicine initiatives. Anticipated market growth is driven by rising disease prevalence, intensified R&D efforts, and increasing adoption of early toxicity testing. However, challenges including high initial discovery costs and limited awareness of biomarker technologies may impede growth. Conversely, emerging economies present significant opportunities for future market expansion, enhancing the scope for innovative biomarker applications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biomarker Technologies market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biomarker Technologies Market Segmental Analysis

Global Biomarker Technologies Market is segmented by Test Type, Product, Profiling Technology, Research Area, Application and region. Based on Test Type, the market is segmented into Solid Biopsy and Liquid Biopsy. Based on Product, the market is segmented into Biomarker Identification, Validation & Development Research and Routine Biomarker-based tests. Based on Profiling Technology, the market is segmented into Immunoassay, PCR, Imaging Technologies, Mass Spectrometry, NGS, Chromatography, Cytogenetics and Other Profiling Technologies. Based on Research Area, the market is segmented into Genomics, Proteomics, Metabolomics and Other Research Areas. Based on Application, the market is segmented into Biomarker Identification, Validation & Development Research and Routine Biomarker-based tests. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biomarker Technologies Market

Global Biomarker Technologies (GBT) leads the charge in advancing precision medicine through the discovery and validation of innovative biomarkers. Focusing on early disease detection, personalized treatment strategies, and enhanced patient monitoring, GBT develops cutting-edge diagnostics that integrate seamlessly into clinical workflows. Their proprietary technology platforms harness the power of genomics, proteomics, and metabolomics to propel research and development across various therapeutic areas, including oncology, cardiology, and neurodegenerative diseases. By fostering collaborations with academic institutions and pharmaceutical companies, GBT accelerates the translation of scientific discoveries into actionable insights, ultimately elevating the standard of care and improving patient outcomes globally.

Restraints in the Global Biomarker Technologies Market

Global Biomarker Technologies must ensure that its research and development practices adhere strictly to ethical guidelines and regulatory standards concerning patient data privacy and consent. Furthermore, the organization should prioritize diversity and inclusivity within its clinical trials to avoid bias in biomarker validation and enhance the applicability of its findings across different populations. The company must also maintain transparent communication with stakeholders about the limitations and potential risks associated with biomarker applications. Finally, Global Biomarker Technologies is encouraged to seek collaborations that foster innovation while aligning with its mission to improve healthcare outcomes globally.

Market Trends of the Global Biomarker Technologies Market

The Global Biomarker Technologies market is witnessing significant growth, propelled by a surge in personalized medicine initiatives that utilize biomarkers for tailored disease management. Advancements in genomics, proteomics, and molecular diagnostics are enhancing the identification of unique biomarkers, facilitating precise diagnosis and targeted therapeutic strategies. Additionally, there is a strong shift towards non-invasive and minimally invasive testing techniques, particularly liquid biopsies, which enhance patient comfort while improving diagnostic accuracy. This convergence of technology and personalized healthcare is fostering innovation and driving investment in biomarker research and development, positioning the market for robust expansion in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement

Global Biomarker Technologies Market Size by Test Type & CAGR (2025-2032)

• Market Overview
• Solid Biopsy
• Liquid Biopsy

Global Biomarker Technologies Market Size by Product & CAGR (2025-2032)

• Market Overview
• Biomarker Identification, Validation & Development Research
  • Consumables
  • Instruments
  • Services
  • Software
• Routine Biomarker-based tests
  • Consumables
  • Instruments
  • Services
  • Software

Global Biomarker Technologies Market Size by Profiling Technology & CAGR (2025-2032)

• Market Overview
• Immunoassay
  • ELISA
  • Western Blot
  • Protein Microarray
• PCR
• Imaging Technologies
• Mass Spectrometry
• NGS
• Chromatography
• Cytogenetics
• Other Profiling Technologies

Global Biomarker Technologies Market Size by Research Area & CAGR (2025-2032)

• Market Overview
• Genomics
• Proteomics
• Metabolomics
  • Metabolic Flux
  • Lipidomics
  • Others
• Other Research Areas

Global Biomarker Technologies Market Size by Application & CAGR (2025-2032)

• Market Overview
• Biomarker Identification, Validation & Development Research
• Routine Biomarker-based tests

Global Biomarker Technologies Market Size & CAGR (2025-2032)

• North America (Test Type, Product, Profiling Technology, Research Area, Application)
  • US
  • Canada
• Europe (Test Type, Product, Profiling Technology, Research Area, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test Type, Product, Profiling Technology, Research Area, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test Type, Product, Profiling Technology, Research Area, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test Type, Product, Profiling Technology, Research Area, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Waters Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations